Mizuho Americas
News
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

February 26, 2024
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared HolzZealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

Jared Holz, Mizuho Americas, joins ‘Fast Money’ to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.

Share This

Latest Mizuho News

See all news
Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

Mizuho Americas announces $1 million in grants through the Mizuho USA Foundation

January 5, 2026
Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

Nvidia is the most compelling tech stock you can buy right now, says Mizuho’s Jordan Klein

November 18, 2025
VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

VR has been ‘pretty big disappointment’ for Meta, says Mizuho’s Lloyd Walmsley

December 4, 2025

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue